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Introduction: Fusarium spp are ubiquitous fungi recognized as opportunistic agents of human
infections, and can produce severe infections in burn patients. The literature on Fusarium
spp infections in pediatric burn patients is scarce.
Objectives: To describe the clinical and epidemiological features as well as outcome of Fusa-
rium  spp infections in pediatric burn patients.
Patients and methods: Retrospective, descriptive study of Fusarium spp infections in a special-
ized intensive care burn unit.
Results: In 15 patients Fusarium spp infections were diagnosed. Median age was 48 months.
Direct ﬁre injury was observed in ten patients. The median affected burn surface area was
45%.  Twelve patients had a full thickness burn. Fourteen patients had a Garces Index ≥3.
Fungal infection developed at a median of 11 days after burn injury. Fungi were isolated
from burn wound in 14 patients and from the bone in one patient.
Amphotericin B was the drug of choice for treatment followed by voriconazole. Median
time of treatment completion was 23 days. One patient (7%) died of fungal infection-related
causes.Conclusion: In our series Fusarium spp was an uncommon pathogen in severely burnt
patients. The burn wound was the most common site of infection and mortality was low.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
such as Aspergillus  spp, Mucor spp, and Fusarium spp. Fusariumntroductionnfection is the most common and severe cause of morbidity
nd mortality in burn patients.1 The longer survival of this
opulation has increased the frequency of fungal infections.
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The most commonly isolated species is Candida spp and in
recent times there has been an increase in ﬁlamentous fungi
2spp – a ﬁlamentous fungus – is ubiquitous in the environment
and can be found in water and in the soil.3 It mainly produces
infections in individuals with immune disorders caused by
e under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1 – Patients characteristics.
Variable N (IQR) Percentage
(IQR)
Patients 15 100
Age 48 m (12–108)
Male sex 11 73
Burn surface 45 (30–60)
Garces index >3 9 60
Full thickness 12 80
Inhalatory injury 11 73
Mechanical respiratory
assistance
13  87
Central venous catheter 15 100
Vesical catheter 15 100
Time between injury
and infection
11  (4–24)
Concomitant infection
with bacteria
13  87
Time of treatment 23 (17–42)390  b r a z j i n f e c t d 
tumors, use of cytostatics, steroids, presence of diabetes mel-
litus, and HIV infection among others. Burn patients are the
most commonly affected immunocompetent hosts.1,4
Commonly isolated Fusarium spp are F. solani, F. oxysporum,
F. proliferatum, F. verticilliodes, etc.5
The literature on Fusarium spp infections in pediatric
patients with burns is limited. Most publications are case
reports of disseminated Fusarium spp infections in cancer
patients or fungal keratitis infections.6–8
The aim of this study was to describe the epidemiological,
clinical, and microbiological features as well as outcome of
infections due to Fusarium spp in pediatric burn patients.
Patients  and  methods
This was a retrospective, descriptive and observational study
of Fusarium spp infections in a specialized burn intensive care
unit between January 2006 and March 2015.
Inclusion  criteria
All burn patients with clinical and microbiological evidence of
fungal infection by Fusarium spp documented from represen-
tative samples, such as deep burn tissue, and/or blood, and/or
other sterile sites with positive cultures were included.
Deﬁnition
Clinical evidence was deﬁned by local signs of infection such
as drainage of pus, redness or swelling at the margin of the
burn, scar separation, localized necrosis, vesicular lesions,
and/or poor adherence of the graft.
Microbiological evidence was deﬁned by the isolation of
Fusarium spp in deep tissue samples or sterile materials (blood,
purulent materials, and/or urine).
Infection  types
Infections were deﬁned according to the American Burn
Association9:
The Garces’ Index – an index of prediction of severity and
mortality calculated as follows: 40 − patient age × 1 percent-
age burn (if type A), ×2 (if type AB), ×3 (if type B).
• 0–60 points: Grade 1 (slight risk);
• 61–90 points: Grade 2 (moderate risk);
• 91–120 points: Grade 3 (severe risk);
• >121 points: Grade 4 (critical risk).
Depth  of  burn
• Type A: superﬁcial burn with erythema and hyperalgesia;
• Type AB: pink-white intermediate-color scar, and hypoalge-
sia;
• Type B or “full thickness”: deep, white or black scar and
analgesia.Microbiology
In addition to regular bacteriological study, all materials were
processed for mycological study.Mortality 1 7
Days of hospitalization 55 (22–60)
Results
A total of 15 patients were infected by Fusarium spp during
the study period. The mechanism of burn was direct ﬁre in 10
patients (66%), hot liquids in four (27%), and electricity in one
case (7%); 87% (n = 13) were male. Median age was 48 months
(IQR 12–108 months). The median body surface area burned
was 45% (IQR 30–60%). Eighty percent of patients (n = 12) had
deep burns (type B); 60% (n = 9) had a Garces’ index of 3, 33%
(n = 5) an index of 4, and the remaining 7% (n = 1) an index of 2.
The median time from burn injury to onset of fungal infec-
tion was 11 days (IQR 4–24 days). All patients had central lines
with a median dwell time of 20 days (IQR 12–30). Of all patients,
87% (n = 13) required mechanical ventilation with a median of
16 days (IQR 10–30). The most common site of microbiological
isolation was the burn wound in 15 patients (100%) and bone in
one patient (7%). In one patient (7%) Fusarium spp was isolated
from blood cultures. In 87% of cases (n = 13) concomitant bac-
terial infections were found. Empirical antifungal treatment
was  started with amphotericin B deoxycholate in 14 patients
(93%) and voriconazole in one patient (7%). All patients were
switched to treatment with voriconazole after microbiological
isolation of Fusarium spp. Median antifungal treatment was 23
days (IQR 17–42 days). No adverse events related to the use of
antifungal agents were reported. The combination of medical
treatment using amphotericin B, voriconazole, and surgical
removal of infectious foci was effective in all cases. The
median length of hospital stay was 55 days (IQR 22–60 days).
Only one patient (7%) died, 14 days after admission due to
septic shock related to Fusarium spp infection (Tables 1 and 2).
Discussion
Infections remain the leading cause of mortality in burn
patients.1 The use of topical and systemic antimicrobials
along with infection-control measures has reduced the inci-
dence of bacterial infections1; however, fungal infections have
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Table 2 – Infection characteristics.
Variable n Percentage
Wounds infection 15 100
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1Bloodstream 1 7
Bone 1 7
emained stable showing an incidence between 6 and 40% in
ifferent series.1,5,6
In a previous study conducted at our center we reported
n 128 infections in 84 patients of which 53 cases (20%)
ad a documented fungal etiology.4 Some risk factors for
eveloping fungal infections in burn patients are extremes
f age, large body surface burned (≥40%), inhalation syn-
rome, requirement for mechanical ventilation, use of broad
pectrum antibiotics, prolonged use of central venous and
ladder catheters, presence of diabetes mellitus, and par-
nteral nutrition.2,3,10,11
Progression from fungal colonization to infection of the
ound is directly related to the body surface area burned.
herefore, close monitoring of patients with large surfaces
urned (≥40%) is recommended to establish early therapeutic
easures.12
Different studies in the literature have reported a higher
ncidence of fungal infections in more  severe burns.1,3,4,6 In
his series, the median body surface area burned was 45%,
eﬂecting the severity of the study sample at high risk for
he occurrence of fungal infections in line with published
iterature.6,10
Candida spp is the most frequently involved species in
ungal infections in burns. In recent times the incidence of ﬁl-
mentous fungi such as Aspergillus spp, and to a lesser extent
ucor spp and Fusarium spp, has increased.2 In a previous
tudy on fungal infections in our center the most frequently
solated fungus was Candida albicans (3.4%).13 In this study
ungal infections occurred from the second week of hospi-
alization (median 11 days), coinciding with several other
eports.2,3,11
Fusarium can be isolated by tissue biopsies that may show
he presence of ﬁlamentous fungi in and around vessels of the
ermis, thrombosis, and tissue necrosis. Blood cultures may
e positive in 50–70% of cases in immunocompromised host
nfections.14,15
The most common site of infection is the burn
ound.1,3,4,14 In this study 100% of patients had infection of
he burn wound and only one (7%) had bone involvement.
dditionally, fungemia was detected in only one patient (7%).
Early treatment of localized forms is essential to prevent
he spread of Fusarium spp. Mortality rates have been reduced
ith early debridement of injuries combined with antifungal
reatment.15–17
In our burn unit, amphotericin B deoxycholate or lipid
ormulations are used as empirical treatment against ﬁlamen-
ous fungi. When Fusarium spp is isolated voriconazole is the
rug of choice. The total duration of treatment varies accord-
ng to the extension of the infection. Some studies reported a
reatment duration of at least two weeks after the last fun-
al isolation coinciding with the management approach in
ur burn unit.2,11,18 Mortality due to fungal infections varies
etween 75 and 90% and is associated with a burned surface
16;2 0(4):389–392 391
area between 40% and 60%.1,10,19 Some studies found no differ-
ence in mortality rates according to the fungal agent involved.
In contrast, the study by Schaal et al.20 found that patients
with Aspergillus spp infections had a 30% mortality whereas
none of those infected with Fusarium spp died, in line with the
low mortality rate found in our study.
Nir Paz et al.3 reported an 11% mortality rate in Fusarium
spp infections in different inmunocompromised patients with
a higher risk in patients with burns.
In our series, one patient died of septic shock due to infec-
tion by Fusarium spp, representing a mortality rate of 7%
in the study period, which is lower than that found in the
literature.11–20
Conclusions
Fusarium spp was a rarely isolated pathogen in burned patients
in our unit. The burn wound was the most frequent site of
isolation. Mortality was low.
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